Children who have experienced the rare and potentially life-threatening multisystem inflammatory syndrome in children (MIS-C), which can develop within four weeks of exposure to the virus that causes COVID-19, are being followed closely in a multidisciplinary clinic at Monroe Carell Jr. Children’s Hospital at Vanderbilt.

Vanderbilt University Medical Center, an original member institution of the National Institutes of Health’s Undiagnosed Diseases Network, (UDN) is launching its own program, the Vanderbilt Undiagnosed Diseases Program (VUDP), which will operate alongside the UDN. The VUDP goal is to expand services to many more patients who are living with the often-dire consequences of an undiagnosed disease.

Five Vanderbilt University Medical Center faculty members have received Young Physician-Scientist Awards from the American Society of Clinical Investigation (ASCI), an elite honor society of physician-scientists.

Vanderbilt University Medical Center is participating in a national phase 1 clinical trial in healthy adults of an investigational vaccine against the B.1.351 variant of the COVID-19 virus that was first identified in South Africa.

Monroe Carell Jr. Children’s Hospital at Vanderbilt is set to begin a phase 2/3 clinical trial to study the safety and efficacy of the Moderna COVID-19 vaccine in children.

Monroe Carell Jr. Children’s Hospital at Vanderbilt’s pediatric primary care clinics have earned the National Committee for Quality Assurance’s (NCQA) Patient-Centered Medical Home Recognition for demonstrating evidence-based practices that ensure excellence and quality of care for all patients and families.

Statewide stay-at-home orders put in place as Tennessee fought to control the spread of coronavirus last March were associated with a 14% lower rate of preterm birth, according to a research letter published today in JAMA Pediatrics.